£6m boost for Scottish genomic medicine

"This funding creates a unique opportunity to translate the investment of Scottish Universities into immediate healthcare benefits for Scottish patients. The remarkable advances in genome technology over the past five years will now be available to patients in the Scottish NHS, bringing a new dimension of healthcare to Scottish patients with cancer and inherited diseases."

Professor Tim Aitman, Co-PI of SGP and Director of CGEM, University of Edinburgh

1st March 2016

 

We are delighted to announce the award of £6M to the Scottish Genomes Partnership. Scotland’s Chief Scientist Office has awarded £4m to The Scottish Genomes Partnership, with an additional £2m from the UK’s Medical Research Council.

The funding will allow scientists to decode and analyse the entire genetic make-up of more than 3000 people with cancer and genetic diseases in Scotland. Linking these genetic data with clinical information will enable more precise molecular diagnoses for patients in the Scottish NHS, leading to more personalised treatment and selection of drug therapies. It will also bring new understanding of the causes of both rare and common diseases, opening the door to the development of new treatments.

An additional £3.5 million has been made available by Scottish Enterprise to support industry-led projects in the field of genomic medicine that will stimulate business opportunities.

Further details are available on the Scottish Government and University of Edinburgh websites.

 

More information on the Genomic Medicine Industrial Catalyst Fund can be found on the Scottish Enterprise website.

© 2020 Scottish Genomes Partnership

Scottish Genomes Partnership gratefully acknowledges the funding received from the Chief Scientist Office of the Scottish Government Health Directorates and the Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative.